
Therapies Targeting ASD Core Symptoms























Often the symptoms of Autism Spectrum Disorder (ASD) are broken down into “core symptoms” and associated symptoms. Core symptoms are the fundamental aspects of ASD that are present in all individuals diagnosed with this disorder, while the associated symptoms may or may not be present in an ASD individual. To date, there are no FDA-approved drugs to treat the core symptoms of autism.
According to the Diagnostic and Statistical Manual of Mental Disorders 5 (DSM-5), released in May 2013, an individual with ASD must show deficits under two broad categories:
1. Deficits in social interactions and communication
2. Restricted or repetitive patterns of behavior and interests
Below, you will find a selection of evidence-based and emerging therapies that target one or more ASD core symptoms:

Behavioral therapy aims to utilize this theory by providing an environment that is conducive for developmental progress.ABA uses the principles of behavioral therapy to elicit positive changes in an individual’s behavior. Both Wikipedia and Autism Speaks provide detailed information about ABA techniques and benefits for autism.

In one study, researchers show that ESDM leads to a better response to stimuli by the brain’s prefrontal cortex. In the study, scientists used electroencephalography (EEG)—a test that measures electrical activity along the scalp—on children between 18 and 30 months of age. After two years, the cortical activity of children with autism who participated in ESDM approximated that of children without ASD when they were shown images of faces.3 The findings demonstrate that the brains of children with ASD can process social stimuli in a typical manner when the disorder is addressed early in life using ESDM. Thus, the severity of ASD can possibly be allayed by way of early intervention.

In a study at University of California, Davis, MIND Institute, symptomatic infants between seven and 15 months of age, and their parents, participated in a 12-week, low-intensity pilot program. During weekly sessions, highly trained therapists coached parents in individualized behavioral therapies, which parents continued in the home environment. By 18 months, the children who participated in Infant Start had significantly fewer autism symptoms than the children of families who chose not to enroll in the pilot study.4 This study supports the idea that very early treatment for autism may alleviate some of the core symptoms associated with the disorder.

In 2014, researchers reported in the Journal of Child Psychology and Psychiatry that parent-administered PRT in the home setting led to significant improvement in the number of utterances—such as saying “ball” to receive a ball. Future studies could better examine PRT impact on social skills and determine the ideal balance of clinical interventions and at-home therapy.5


In a 2013 research report, researchers tested the effect of intranasal oxytocin supplementation on brain activity of adult individuals with ASD in response to social stimuli. Oxytocin supplementation significantly increased amygdala activity in response to faces.8
Ongoing clinical trials are testing if therapeutic oxytocin can alleviate social cognition difficulties in children with ASD. Also published in 2013, a small, randomized, double-blind study looking at brain scans of children receiving a single dose of nasal oxytocin showed increased brain activity in areas associated with motivation, higher information processing, sleep, decision-making, and social perception.9 While it used a small sample size, this study demonstrates that therapeutic oxytocin might help children with ASD respond more appropriately to social versus non-social stimuli.

Nutritional supplementation aimed at increasing glutathione—an antioxidant known to be lower in some people with autism—improves autism-related behaviors, according to a report published in 2013. In the study, 40 children with autism who had low levels of active glutathione received supplements of methylcobalamin and folinic acid, factors in glutathione production and activation. The children made large gains in expressive communication, daily living skills, and various social skills with minimal side effects.10 This preliminary study warrants further investigation with a randomized, double blind trial.
Other researchers have reported that sulforaphane—an antioxidant present in vegetables like broccoli sprouts—may ameliorate autism symptoms. According to the researchers’ study, ASD behavioral assessment scores returned to baseline when they stopped sulforaphane administration.11

Evidence Legend | |
---|---|
![]() |
Research-supported – a therapy with the highest level of evidence for safety and effectiveness based on rigorous scientific research and well-controlled clinical trials. |
![]() |
Promising – a therapy that is being actively researched in scientific studies and clinical trials with promising results |
![]() |
Suggestive – a therapy that has been known for some time but is not actively researched at present OR a novel therapy having current research of one or two preliminary studies showing suggestive results |
![]() |
No evidence available – a therapy that lacks any evidence-based support for effectiveness or safety |
References: |
|